Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress

被引:31
作者
Kim, J
Adam, RM
Freeman, MR
机构
[1] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
关键词
D O I
10.1158/0008-5472.CAN-05-0942
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) accumulates in the nucleus in aggressive transitional cell carcinoma (TCC) cells and this histologic feature is a marker of poor prognosis in human bladder cancer tissues. Here we report that HB-EGF can be exported from the nucleus during stimulated processing and secretion of the growth factor. Production of reactive oxygen species (ROS) resulted in mobilization of the HB-EGF precursor, proRB-EGF, from the nucleus of TCCSUP bladder cancer cells to a detergent-resistant membrane compartment, where the growth factor was cleaved by a metalloproteinase-mediated mechanism and shed into the extracellular space. Inhibition of nuclear export suppressed HB-EGF shedding. Production of ROS resulted in EGF receptor (EGFR) and Akt1 phosphorylation in HB-EGF-expressing cells. HB-EGF also stimulated cell proliferation and conferred cytoprotection when cells were challenged with cisplatin. These findings show that the nucleus can serve as an intracellular reservoir for a secreted EGFR ligand and, thus, can contribute to an autocrine loop leading to cell proliferation and protection from apoptotic stimuli.
引用
收藏
页码:8242 / 8249
页数:8
相关论文
共 50 条
[1]
Adam RM, 2003, CANCER RES, V63, P484
[2]
Epidermal growth factor (EGF)-induced generation of hydrogen peroxide - Role in EGF receptor-mediated tyrosine phosphorylation [J].
Bae, YS ;
Kang, SW ;
Seo, MS ;
Baines, IC ;
Tekle, E ;
Chock, PB ;
Rhee, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (01) :217-221
[3]
BARNARD JA, 1994, J BIOL CHEM, V269, P22817
[4]
Novel approaches with targeted therapies in bladder cancer - Therapy of bladder cancer by blockade of the epidermal growth factor receptor family [J].
Bellmunt, J ;
Hussain, M ;
Dinney, CP .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 46 :S85-S104
[5]
Chen Chu-Huang, 2004, Current Vascular Pharmacology, V2, P33, DOI 10.2174/1570161043476500
[6]
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients [J].
Crombet, T ;
Osorio, M ;
Cruz, T ;
Roca, C ;
del Castillo, R ;
Mon, R ;
Iznaga-Escobar, N ;
Figueredo, R ;
Koropatnick, J ;
Renginfo, E ;
Fernández, E ;
Alvárez, D ;
Torres, O ;
Ramos, M ;
Leonard, I ;
Pérez, R ;
Lage, A .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1646-1654
[7]
Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO
[8]
2-S
[9]
Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody [J].
Foon, KA ;
Yang, XD ;
Weiner, LM ;
Belldegrun, AS ;
Figlin, RA ;
Crawford, J ;
Rowinsky, EK ;
Dutcher, JP ;
Vogelzang, NJ ;
Gollub, J ;
Thompson, JA ;
Schwartz, G ;
Bukowski, RM ;
Roskos, LK ;
Schwab, GM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03) :984-990
[10]
CRM1 is responsible for intracellular transport mediated by the nuclear export signal [J].
Fukuda, M ;
Asano, S ;
Nakamura, T ;
Adachi, M ;
Yoshida, M ;
Yanagida, M ;
Nishida, E .
NATURE, 1997, 390 (6657) :308-311